Aug 12 (Reuters) - Anti-wrinkle injection maker Revance
Therapeutics ( RVNC ) will be acquired by private skincare
company Crown Laboratories in a take-private deal worth $924
million, including debt, the two companies said on Monday.
(Reporting by Leroy Leo in Bengaluru; Editing by Devika
Syamnath)